Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

NRW.BANK

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 93
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 63
Rounds per year 4.23
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 8
Key employees 7
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Medical
  • Information Technology
Summary

NRW.BANK is the famous Corporate Investor, which was founded in 2002. The company was established in Europe in Germany. The main office of represented Corporate Investor is situated in the Du00fcsseldorf.

For fund there is a match between the location of its establishment and the land of its numerous investments - Germany. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline CHRONEXT, HoloBuilder, Scienion Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, E-Commerce.

We also calculated 7 valuable employees in our database.

The typical startup value when the investment from NRW.BANK is 10-50 millions dollars. The real fund results show that this Corporate Investor is 6 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 5 - 10 millions dollars. The higher amount of exits for fund were in 2019. The high activity for fund was in 2014. Comparing to the other companies, this NRW.BANK performs on 17 percentage points less the average number of lead investments. The fund is constantly included in 2-6 investment rounds annually.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the NRW.BANK, startups are often financed by KfW, Capnamic Ventures, S-Venture Capital Dortmund. The meaningful sponsors for the fund in investment in the same round are High-Tech Gru00fcnderfonds, KfW, Capnamic Ventures. In the next rounds fund is usually obtained by Creathor Ventures, Peppermint Venture Partners, Capnamic Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of NRW.BANK:
Typical Co-investors
NRW.BANK is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after NRW.BANK:

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sphingotec GmbH

Biotechnology
$5M08 Aug 2024 Hohen Neuendorf, Brandenburg, Germany

ECO2GROW

Energy
Energy Management
GreenTech
$4M17 Jul 2024 Bonn, Nordrhein-Westfalen, Germany

Black Semiconductor

Electronics
Manufacturing
Semiconductor
$30M12 Jun 2024 Aachen, Nordrhein-Westfalen, Germany

Prothea Technologies

$14M09 Apr 2024 -

CryoTherapeutics

Biotechnology
Clinical Trials
Health Care
Medical
Therapeutic Devices
Therapeutics
$11M02 Apr 2024 Potsdam, Brandenburg, Germany

Companyon Analytics

Analytics
Cloud Infrastructure
Information Technology
$2M21 Sep 2023 Düsseldorf, Nordrhein-Westfalen, Germany

consalio

Financial Services
Information Technology
Software
$1M11 Jul 2023 Düsseldorf, Nordrhein-Westfalen, Germany

bNear

Software
30 May 2023 -

Elixion Medical

$1M09 May 2023 Munich, Bayern, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent NRW.BANK?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 93
Average round size 8M
Rounds per year 4.23
Peak activity year 2021
Lead investments 9
Follow on index 0.30
Exits 8
Group Appearance index 0.82

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Sphingotec GmbH

Biotechnology
$5M08 Aug 2024 Hohen Neuendorf, Brandenburg, Germany

ECO2GROW

Energy
Energy Management
GreenTech
$4M17 Jul 2024 Bonn, Nordrhein-Westfalen, Germany

Black Semiconductor

Electronics
Manufacturing
Semiconductor
$30M12 Jun 2024 Aachen, Nordrhein-Westfalen, Germany

Prothea Technologies

$14M09 Apr 2024 -

CryoTherapeutics

Biotechnology
Clinical Trials
Health Care
Medical
Therapeutic Devices
Therapeutics
$11M02 Apr 2024 Potsdam, Brandenburg, Germany

Companyon Analytics

Analytics
Cloud Infrastructure
Information Technology
$2M21 Sep 2023 Düsseldorf, Nordrhein-Westfalen, Germany

consalio

Financial Services
Information Technology
Software
$1M11 Jul 2023 Düsseldorf, Nordrhein-Westfalen, Germany

bNear

Software
30 May 2023 -

Elixion Medical

$1M09 May 2023 Munich, Bayern, Germany
Crunchbase icon

Content report

The following text will be sent to our editors: